Cambridge Investment Research Advisors
FEED

Cambridge Investment Research Advisors’s ENvue Medical Inc FEED Stock Holding History

Cambridge Investment Research Advisors’s Portfolio FEED Stock Details FEED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$4K – 3216
2022
Q4 		$4K Hold
1
– – ﹤0.01% 3088
2022
Q3 		$7K Buy
+1
New +$15.6K ﹤0.01% 3029
2022
Q2 		– Hold
0
– – – 3024
2022
Q1 		– Hold
0
– – – 3132
2021
Q4 		– Hold
0
– – – 3144

Other funds holding FEED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFS
Amtrust Financial Services New York $336M AUM 16.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NC
NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return

Cambridge Investment Research Advisors's FEED Position: Q1 2023 in Review

Cambridge Investment Research Advisors sold out of ENvue Medical Inc (FEED) in Q1 2023, closing a stake of 1 share — an estimated $4K sold.

Cambridge Investment Research Advisors first reported a position in FEED in Q3 2022 and held it in 2 quarters. The position peaked at $7K in Q3 2022. 5 funds tracked by Wall St. Rank hold FEED as of Q1 2023.

  • Cambridge Investment Research Advisors reported no remaining ENvue Medical Inc position as of Q1 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1 ENvue Medical Inc share in Q1 2023, an estimated $4K.
  • Cambridge Investment Research Advisors first reported a position in ENvue Medical Inc in Q3 2022 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's ENvue Medical Inc position peaked at $7K in Q3 2022.
  • 5 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2023, filed 11 May 2023.